Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

All forms of Brexit will negatively impact the UK National Health Service (NHS), but the prospect of a no-deal Brexit presents by far the worst scenario, with negative effects on the health care workforce, NHS financing, availability of medicines and vaccines, sharing of information, and medical research, according to a new health policy review published in The Lancet and co-authored by Oxford's Dr Nick Fahy.

© Shutterstock

While the withdrawal agreement negotiated between the UK government and the EU (but not agreed by parliament) offers a more positive scenario compared with a no-deal Brexit, there are serious concerns about the negative impact of Brexit on the NHS beyond the transition period, when the backstop or arrangements envisaged in the political declaration on the future relationship would come into force.

Under either the backstop or political declaration scenarios, the impact of Brexit on the NHS is only slightly less harmful than the no-deal scenario, though the exact impacts vary.

In the new analysis, the authors, who are leading experts in public health and law, use the available legal and political texts on four Brexit scenarios to assess the likely impact on 15 specific aspects of the UK health service.

Read more (University of Oxford website)

Similar stories

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19

Clinical Trials Coronavirus COVID-19 General Research

The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.

Ancient gene mutation found to cause rare hereditary condition

General Research

UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).